Search

UCB SA

Fechado

SetorSaúde

203.2 -1.5

Visão Geral

Variação de preço das ações

24h

Atual

Mín

203.2

Máximo

204.5

Indicadores-chave

By Trading Economics

Rendimento

28M

1.1B

Vendas

16M

4.3B

P/E

Médio do Setor

18.012

48.735

EPS

5.7

Rendimento de Dividendos

0.71

Margem de lucro

26.019

Funcionários

9,000

EBITDA

899M

1.7B

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+19.23% upside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

0.71%

2.24%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-8B

39B

Abertura anterior

204.7

Fecho anterior

203.2

UCB SA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de out. de 2026, 23:52 UTC

News

Dell Technologies Inc shares are moving lower in after-market hours amid inflation concerns affecting tech valuations, despite being named a core AI partner for Honeywell.

16 de out. de 2026, 23:51 UTC

News

Baker Hughes Co. has a market capitalization of approximately $54.96 billion, experiencing a modest increase in after-market trading following Friday's close.

16 de out. de 2026, 23:46 UTC

News

Scholar Rock grants inducement equity awards for 61.02k shares to new employees as part of its strategy to attract talent for ISEMBLYD commercialization.

16 de out. de 2026, 23:46 UTC

News

Apollo Commercial Real Estate Finance Inc. plans to voluntarily delist from the NYSE, with the last trading day expected on November 6, 2026.

16 de out. de 2026, 23:41 UTC

News

General Electric Co shares are moving lower in after-market trading following a deal with CFM International for over 300 LEAP-1B engines for Turkish Airlines.

16 de out. de 2026, 23:41 UTC

News

Boeing Co. secures an $80 million contract from the U.S. Navy for the MQ-25A Stingray unmanned aircraft system, expected to be completed by October 2031.

16 de out. de 2026, 23:41 UTC

News

Tesla Inc shares are trading modestly lower in after-market hours, continuing a trend of decline and remaining significantly below their 20-day moving average.

16 de out. de 2026, 23:36 UTC

News

Hingham Institution for Savings reports third-quarter net income of $12.67 million, a decline from $17.30 million year-over-year, with overall performance metrics indicating a decrease.

16 de out. de 2026, 23:31 UTC

News

Celanese announces global price increases for LCP products, citing strong demand and rising costs, as shares decline in after-market trading.

16 de out. de 2026, 23:31 UTC

Correlated Moves
News

Coinbase Global Inc shares are trading modestly lower in after-market hours, influenced by a decline in Bitcoin prices and broader market trends.

16 de out. de 2026, 23:16 UTC

News

In after-market trading, Steel Dynamics Inc is rising, with analysts expecting earnings of approximately $5.40 per share on revenue of around $6.57 billion.

16 de out. de 2026, 23:12 UTC

Social Media
News

Morgan Stanley lowers Netflix's price target to $80 from $83, citing stagnant viewing hours and concerns over engagement trends ahead of earnings report.

16 de out. de 2026, 23:11 UTC

News

Lyft Inc shares declined in after-market trading following the announcement of its new premium chauffeur brand, Alcove, amid broader market weakness.

16 de out. de 2026, 23:11 UTC

News

RTX Corp's Raytheon business secured a $729 million contract for the Ku-band Radio Frequency Sensor and Coyote interceptor, boosting shares higher in after-market hours.

16 de out. de 2026, 23:06 UTC

News

Gartner Inc shares traded lower in after-market hours, following a decline from Friday's close amid concerns over rising U.S. import and export prices.

16 de out. de 2026, 23:06 UTC

Correlated Moves
News

Pomerantz LLP has initiated a class action lawsuit against FuelCell Energy Inc, alleging securities fraud and unlawful business practices involving the company and its officers.

16 de out. de 2026, 23:06 UTC

News

UPS is trading slightly lower in after-market hours, following a brief high earlier in the session, amid ongoing service enhancements and cost management efforts.

16 de out. de 2026, 23:02 UTC

News

Meta Platforms is set to report Q3 earnings on October 21, with analysts forecasting revenue of $63.31 billion and EPS of $5.60.

16 de out. de 2026, 23:02 UTC

Social Media
News

Bank of America Corp's Board has authorized cash dividends of $1.15K for Series F and G, and $0.27806 for Series E, payable in late 2026.

16 de out. de 2026, 23:02 UTC

News

Shah Capital has withdrawn its registration as an investment adviser and reduced its stake in Novavax to 6.39%, selling 2.87 million shares at $11.35 each.

16 de out. de 2026, 23:01 UTC

News

Citigroup maintains Neutral rating on Fiserv Inc and lowers its price target to $53 in a report published after market hours.

16 de out. de 2026, 23:01 UTC

News

Citigroup reaffirms Buy rating on Walt Disney Co and raises price target to $140, indicating confidence in the company's future performance.

16 de out. de 2026, 23:01 UTC

News

Viatris receives FDA approval for Ryzumvi to treat presbyopia in adults and seeks U.S. partners for commercialization under a licensing agreement with Opus Genetics.

16 de out. de 2026, 23:01 UTC

News

Goldman Sachs Group Inc shares are trading modestly lower in after-market hours, retracing to their lowest point of the day and below the 20-day moving average.

16 de out. de 2026, 23:01 UTC

News

Coca-Cola Co shares traded lower in after-market hours, despite KFC's upcoming switch to its beverages in U.S. restaurants starting January 2027.

16 de out. de 2026, 22:51 UTC

News

Navigator Holdings Ltd shares declined in after-market hours, continuing a downward trend for six consecutive sessions amid broader market declines.

16 de out. de 2026, 22:51 UTC

Correlated Moves
News

Power Integrations Inc granted 25.32k RSUs and 1.34k PSUs to 12 employees as a material inducement to employment, effective October 15, 2026.

16 de out. de 2026, 22:21 UTC

News

Moody's Corp shares are trading modestly lower in after-market hours, continuing a decline from Friday's close.

16 de out. de 2026, 20:31 UTC

News

Delek US Holdings, Inc. will hold a conference call on November 6, 2026, to discuss third-quarter results, with a press release before market open.

16 de out. de 2026, 20:21 UTC

News

Ames National Corp reported Q3 EPS of $0.80, surpassing the $0.68 estimate, with sales increasing to $20.42 million from $16.58 million year-over-year.

Comparação entre Pares

Variação de preço

UCB SA Previsão

Preço-alvo

By TipRanks

19.23% parte superior

Previsão para 12 meses

Média 94.86 EUR  19.23%

Máximo 125 EUR

Mínimo 74 EUR

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para UCB SA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

7 ratings

4

Comprar

1

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre UCB SA

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
help-icon Live chat